Seroprevalence of human T lymphtropic virus (HTLV) among tissue donors in Iranian tissue bank

Cell and Tissue Banking

Volumn 10, Issue 3, 2009, Pages 247-252

  Arjmand, Babak ^a   Aghayan, Seyed Hamidreza ^a   Goodarzi, Parisa ^b   Farzanehkhah, Mohammad ^b   Mortazavi, Seyed Mohamadjavad ^b   Niknam, Mohamad Hossein ^b   Jafarian, Ali ^c   Arjmand, Farzin ^d   Jebelly Far, Soheyla ^e  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d URMIA UNIVERSITY   (Iran)

^e ALLAMEH TABATABA'I UNIVERSITY   (Iran)

Author keywords

Donor; Homograft; HTLV; Prevalence; Tissue

Indexed keywords

HUMAN T CELL LEUKEMIA VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGED; ALLOGRAFT; AMNION; ARTICLE; BONE GRAFT; CADAVER DONOR; CHILD; CONTROLLED STUDY; DONOR SELECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS; INFANT; INFECTION RISK; IRAN; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; ORGAN PRESERVATION; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; QUALITY CONTROL; RISK REDUCTION; SAFETY; SCHOOL CHILD; SEROLOGY; SEROPREVALENCE; SKIN GRAFT; UNITED STATES;

ADULT; FEMALE; HTLV-I ANTIBODIES; HTLV-II ANTIBODIES; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; IRAN; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; TISSUE BANKS; TISSUE DONORS;

EID: 67651122949     PISSN: 13899333     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10561-008-9117-9     Document Type: Article

References (24)

1. Ajami A, Faridhosseini R, Tabarestani N (2000) Seroepidemiological survey of HTLV-I/II in blood donors of Mazandaran in 1999. J Mazandaran Univ Med Sci 10(26):45-48
2. American Association of Tissue Banks (2002) Standards for tissue banking, 10th edn. AATB, Mclean
3. Arjmandi F, Shahriari M, Sadeghi Hassanabadi M (2003) A comparative study of the prevalence of HTLV-I infection in leukemia/non-hodgkins lymphoma patients, thalassemic patients and blood donors. J Shahid Sadoughi Univ Med Sci Health Serv 10(4):25-28
4. Barnett JR, McCauley RL, Schutzler S, Sheridan K, Heggers JP (2001) Cadaver donor discards secondary to serology. J Burn Care Rehabil 22(2):124-127. doi: 10.1097/00004630-200103000-00007
5. Faridhosseini R, Ghafari J, Miri S, Nasirian A, Rafatpanah H (2005) Seroepidemiology of HTLV-1 in Neishabour. Med J Mashhad Univ Med Sci 47(86):417-424
6. Gibellini D, Monari P, Sassi M, Carla RM (2003) A rapid hemi-nested PCR for HTLV-1 detection. J Clin Virol 28:341-343. doi: 10.1016/ S1386-6532(03)00080-5
7. Heck EL, Baxter CR (1994) Guidelines preventing "dilution false negative" in invivo laboratory testing of donor population. Cornea 13:290-293. doi: 10.1097/00003226-199407000-00002
8. Hoft RH, Pfluger SC, Forster RK et al (1997) Clinical evidence for hepatitis B transmission resulting from corneal transplantation. Cornea 16:132-137. doi: 10.1097/00003226-199703000-00003
9. Jacob F, Santos-Fortuna E, Azevedo RS, Caterino-de-Araujo A (2008) Serological pattern and temporal trends of HTLV-1/2 infection in high-risk population attending public health units in Sao Paulo, Brazil. J Clin Virol 42:149-155. doi: 10.1016/j.jcv.2008.01.017
10. Jaudas F, Teixeira L, Proenca A (2005) Coimbra university hospital's bone and tissue bank: Twenty-two years of experience. Transplant Proc 37:2799-2801. doi: 10.1016/j.transproceed.2005.05.004
11. Kealy PG (1997) Disease transmission by means of allograft. J Burn Care Rehabil 18(suppl):S10. doi: 10.1097/00004630-199701001-00005
12. Lefor WM, Shires DL, McGonigle AF (1995) Hemoconcentration prior to serology testing in hemodiluted cadaver bone and tissue donors. Clin Transplant 9:297-300
13. Pianigiani E, Risulo M, Lerardi F, Sbano P, Andreassi L, Fimiani M, Caudai C, Valensin PE, Zazzi M (2006) Prevalence of skin allograft discards as a result of serological and molecular microbiological screening in a regional skin bank in Italy. Burns 32:348-351. doi: 10.1016/j.burns.2005.10.005
14. Pirnay JP (1997) HIV transmission by transplantation of allograft skin: a review of the literature. Burns 23:2. doi: 10.1016/ S0305-4179(96)00081-2
15. Pourkarim MR, Khamisipour GHR, Zandi K, Roustaei MR (2004) Prevalence of HTLV-I & II antibodies in blood donors in Bushehr Province. Iranian S Med J 6(2):161-164
16. Pourkarim MR, Hajiani GHR, Khamisipour GHR, Ardeshirdavani N, Tahmasebi R (2005) Seroepidemiological investigation of HTLV-I & II infection among bushehrian multi-transfused patients in 2003. Khoon (Hematology). Res J 2(4):99-104
17. Rostamzadeh Z, Baradaran M, Sepehrvand N (2008) Survey of the seroprevalence of HTLV I/II in hemodialysis patients and blood donors in Urmia. Saudi J Kidney Dis Transplant 19(5):838-841
18. Sani AT (2001) Serologic prevalence of HTLV among blood donors in Mashhad (Northeastern Iran). Arch Iran Med 4:25-26
19. Sanzen L, Carlsson A (1997) Transmission of human T-cell lymphotrophic virus type1 by a deep-frozen bone allograft. Acta Orthop Scand 68(1):70-76
20. Simonds RJ, Holmberg SD, Hurwits RL et al (1992) Transmission of human immunodeficiency virus type I from a seronegative organ and tissue donor. N Engl J Med 236:726-732
21. Stanworth SJ, Warwick RM, Ferguson M, Barbara JAA (2000) UK survey of virological testing of cadaver tissue donors. Vox Sang 79:227-230. doi: 10.1159/000056735
22. 1 and HCV infections among antibody-negative blood donors by nucxleic acid-amplification testing. N Engl J Med 351:760-768. doi: 10.1056/NEJMoa040085
23. Zahariadis G, Plitt SS, O'Brien S, Yi QL, Fan W, Preiksaitis JK (2006) Prevalence and estimated incidence of blood-born viral pathogen infection in organ and tissue donors from Northern Alberta. Am J Transplant 6:1-9. doi: 10.1111/j.1600-6143.2005.01164.x
24. Zou S, Dodd RY, Stramer SL, Strong M (2004) Probability of viremia with HBV, HCV, HIV and HTLV among tissue donors in the United State. N Engl J Med 351:751-759. doi: 10.1056/NEJMoa032510